Nutri Pharmaceuticals Research Inc(NRPR)
USD --+0.00%
Reward41Moderate
Risk45Moderate
📊75%Data
Thin -39% profit margin
NRPR
+0.0 · +0.00%
USD · PINK
Nutri Pharmaceuticals Research Inc | Healthcare
Capital Destroyer
Market Cap:2.11M
ℹ️
Reward Rating
41
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
45
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on NRPR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Nutri Pharmaceuticals Research Inc?

Resilient Healthcare Corp engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide.

NRPR · Verdict

Moderate reward · moderate risk

NRPR stands out on balance sheet and volatility, but watch the profitability signal.

Based on 88% data coverage

NRPR · Verdict

What’s working & what to watch

Strengths 3

  • Balance sheet75/100

    Current ratio 1.08

  • Volatility75/100

    Above average

  • Valuation67/100

    Above average

Watchouts 3

  • Profitability9/100

    -125% net margin · 0% ROE

  • Cash flow27/100

    -125% net margin

  • Growth41/100

    Earnings +2069.4% CAGR

Model-based scoring. For information only — not financial advice.

What is Nutri Pharmaceuticals Research Inc?

Resilient Healthcare Corp engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.11M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (41)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.11M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.059
52 Week Low0.0115
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding105M
No. of EmployeesN/A
IndustryHealth Information Services
ExchangePINK
Beta-0.855
CurrencyUSD